
Consider buying shares of Oddity (ODD), as its recent -22% price drop appears disconnected from its strong financial performance and raised future guidance. The company's AI-powered, direct-to-consumer business model drives superior profit margins and customer loyalty, making it a more compelling investment than competitor ELF. ODD is growing revenue over 20% and is set to launch a new dermatology brand in the second half of the year, providing a potential future catalyst. Management also has a $103 million share buyback program in place, which could support the stock price at these lower levels. Adding a high-growth name like ODD can provide valuable diversification for portfolios concentrated in other sectors.

By @BeatTheDenominator